Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16127358rdf:typepubmed:Citationlld:pubmed
pubmed-article:16127358lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:16127358lifeskim:mentionsumls-concept:C0004259lld:lifeskim
pubmed-article:16127358lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16127358lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:16127358lifeskim:mentionsumls-concept:C1611646lld:lifeskim
pubmed-article:16127358pubmed:issue9lld:pubmed
pubmed-article:16127358pubmed:dateCreated2005-8-29lld:pubmed
pubmed-article:16127358pubmed:abstractTextVasopressin is an alternative drug to adrenaline in intractable ventricular fibrillation. However, vasopressin can cause significant bradycardia, resulting in reduced cardiac output. We investigated whether pre-treatment with atropine abrogates vasopressin-induced bradycardia in a beating-heart canine model.lld:pubmed
pubmed-article:16127358pubmed:languageenglld:pubmed
pubmed-article:16127358pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16127358pubmed:citationSubsetIMlld:pubmed
pubmed-article:16127358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16127358pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16127358pubmed:statusMEDLINElld:pubmed
pubmed-article:16127358pubmed:monthSeplld:pubmed
pubmed-article:16127358pubmed:issn1234-1010lld:pubmed
pubmed-article:16127358pubmed:authorpubmed-author:ParetGideonGlld:pubmed
pubmed-article:16127358pubmed:authorpubmed-author:Ben-AbrahamRo...lld:pubmed
pubmed-article:16127358pubmed:authorpubmed-author:EfratiOriOlld:pubmed
pubmed-article:16127358pubmed:authorpubmed-author:BibiHaimHlld:pubmed
pubmed-article:16127358pubmed:authorpubmed-author:Modan-MosesDa...lld:pubmed
pubmed-article:16127358pubmed:issnTypePrintlld:pubmed
pubmed-article:16127358pubmed:volume11lld:pubmed
pubmed-article:16127358pubmed:ownerNLMlld:pubmed
pubmed-article:16127358pubmed:authorsCompleteYlld:pubmed
pubmed-article:16127358pubmed:paginationCR410-4lld:pubmed
pubmed-article:16127358pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:meshHeadingpubmed-meshheading:16127358...lld:pubmed
pubmed-article:16127358pubmed:year2005lld:pubmed
pubmed-article:16127358pubmed:articleTitleAtropine aborts bradycardic effect of endotracheally administered vasopressin.lld:pubmed
pubmed-article:16127358pubmed:affiliationDepartemnt of Pediatric Pulmonology, of the Chaim Sheba Medical Center, Tel-Hashomer, Israel. ori.efrati@sheba.health.gov.illld:pubmed
pubmed-article:16127358pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16127358pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed